Literature DB >> 18726939

Clean intermittent self-catheterization: a burden for the patient?

Thomas M Kessler1, Gloria Ryu, Fiona C Burkhard.   

Abstract

AIM: To assess patients' perception of clean intermittent self-catheterization (CISC) for voiding dysfunction. PATIENTS AND METHODS: A total of 101 patients performing CISC because of voiding dysfunction were invited to participate in this questionnaire survey. The response rate was 91% (92/101).
RESULTS: The mean time over which CISC was performed was 5 years (standard deviation (SD) +/- 6.3) and the mean frequency of CISC per day was three times (SD +/- 2). Almost 80% (72/92) of the patients perceived CISC as easy or very easy and CISC did not interfere at all or interfered a little bit with work or other regular daily activities in more than 80% (76/92). Almost 90% (80/92) reported no or minimal pain while performing CISC. This did not interfere at all or interfered a little bit with work or other regular daily activities in almost 90% (80/92). Quality of life improved considerably due to CISC in more than 60% (56/92) and 12% (11/92) complained of a deterioration. In multivariable analysis, severe pain performing CISC (odds ratio 20.9, 95% confidence interval 1.7-259.9, P = 0.018) was the only factor that predicted poor quality of life.
CONCLUSIONS: The majority of patients considered CISC to be an easy and painless procedure which did not interfere with daily activities. Consequently, quality of life improved in more than 60% of the patients. Therefore, CISC does not appear to be a burden for the patient and, from a patient's perspective, can be recommended. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 18726939     DOI: 10.1002/nau.20610

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  19 in total

1.  Bladder hypocontractility--extending the indication for LDDM.

Authors:  Georgios Gakis; Milomir Ninkovic; Arnulf Stenzl
Journal:  Nat Rev Urol       Date:  2012-03-27       Impact factor: 14.432

2.  Bladder acontractility: detrusor myoplasty and other options.

Authors:  David A Ginsberg
Journal:  Nat Rev Urol       Date:  2011-04       Impact factor: 14.432

Review 3.  [The relevance of catheterization in neurourology].

Authors:  R Böthig; H Burgdörfer
Journal:  Urologe A       Date:  2012-02       Impact factor: 0.639

4.  What is the true catheterization rate after intravesical onabotulinumtoxinA injection?

Authors:  Devin N Patel; Juzar Jamnagerwalla; Justin Houman; Jennifer T Anger; Karyn S Eilber
Journal:  Int Urogynecol J       Date:  2017-08-14       Impact factor: 2.894

5.  Disability and sustainability: reusable versus single-use catheters for persons with neurogenic bladder due to spinal cord injury.

Authors:  Giulio Del Popolo; Laura Antonucci
Journal:  Spinal Cord Ser Cases       Date:  2020-09-30

6.  Canadian Urological Association Best Practice Report: Catheter use.

Authors:  Lysanne Campeau; Samer Shamout; Richard J Baverstock; Kevin V Carlson; Dean S Elterman; Duane R Hickling; Stephen S Steele; Blayne Welk
Journal:  Can Urol Assoc J       Date:  2020-07       Impact factor: 1.862

Review 7.  Neurogenic bladder: from diagnosis to management.

Authors:  Ellen Goldmark; Benjamin Niver; David A Ginsberg
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

8.  Poor quality of life in patients with urethral stricture treated with intermittent self-dilation.

Authors:  Jessica D Lubahn; Lee C Zhao; J Francis Scott; Steven J Hudak; Justin Chee; Ryan Terlecki; Benjamin Breyer; Allen F Morey
Journal:  J Urol       Date:  2013-06-29       Impact factor: 7.450

9.  Effect of a preoperative self-catheterization video on anxiety: a randomized controlled trial.

Authors:  Sallie S Oliphant; Jerry L Lowder; Chiara Ghetti; Halina M Zyczynski
Journal:  Int Urogynecol J       Date:  2012-07-03       Impact factor: 2.894

10.  Success rates for learning intermittent self-catheterisation according to age and gender.

Authors:  Brian A Parsons; Anita Narshi; Marcus J Drake
Journal:  Int Urol Nephrol       Date:  2012-02-18       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.